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Introduction
Adeno-associated virus (AAV) is a nonpathogenic human virus of the parvovirus family. 1 AAV requires a helper virus from either the adenovirus or herpes virus family for productive infection. In the absence of such a helper virus, AAV integrates into the host chromosome, usually chromosome 19. 2 The ability of AAV to establish a latent infection without causing disease or pathology makes it a good candidate for a gene therapy viral transduction vector. AAV is a nonenveloped virus with a single-stranded linear DNA genome of 4680 bp. 1, 3 Two large open reading frames that are responsible for encapsidation (cap) and replication (rep) are flanked by 145 bp inverted terminal repeats (ITR) which, in the absence of the products of the rep gene, are transcriptionally neutral. The ITR have been shown to be the only cis-acting sequences necessary for rescue from the infectious plasmid, for replication, and for integration of the AAV genome into host chromosomes. 4 AAV infects and integrates into the chromosomes of a wide range of host cells. [5] [6] [7] [8] Recombinant AAV (rAAV) is generated from AAVbased plasmids in which all of the genomic DNA, except for the ITR, has been replaced by the desired gene therapy construct. 5, 9 Recombinant AAV can also integrate into the genome of a wide range of host cells including lymphoid cells, 5, [10] [11] [12] and does not replicate and cannot be rescued upon superinfection with adenovirus unless wild-type AAV is also present. 13 Other advantages of rAAV include its capacity to integrate into nondividing cells, although less efficiently than in replicating cell lines.
14 However, rAAV is limited by the size of DNA that can be packaged to between 3.5 kb and 5 kb and, unlike wild-type AAV, rAAV integrates randomly in the host chromosomes. 15 X-linked hyper IgM (X-HIM) is a primary immune deficiency disease that results from defects in the gene for CD40 ligand. 16 CD40 ligand is a 39 kDa glycoprotein expressed transiently on the surface of activated CD4 + T cells 17 and delivers contact-dependent help to B cells and monocytes. 18 Affected patients suffer from recurrent infections including opportunistic infections, recurrent episodes of neutropenia and autoimmune disease, and have an increased likelihood of developing cancer. 19 Gene transfer of CD40 ligand may be an attractive therapeutic option to patients with X-HIM. However, gene transfer of CD40 ligand will require the maintenance of normal regulation of CD40 ligand gene expression. Aberrant expression of CD40 ligand has been found in patients with active systemic lupus erythemtosis. 20, 21 Furthermore, transgenic overexpression of CD40 ligand in the mouse thymus resulted in disruption of the thymic cortex, a decline in thymocyte numbers and peripheral tissue inflammation and lymphoid hypertrophy. 22, 23 The regulation of expression of CD40 ligand is not as well characterized as that of interleukin-2 (IL-2), a growth factor that is also produced by activated T cells. 24, 25 In order to examine gene transfer of regulated gene expression into T cells, we generated an AAV-based luciferase reporter plasmid under the regulatory control of the IL-2 promoter (IL-2p) and we examined the ability of rAAV to transfer IL-2p-dependent gene expression into human T cell lines. In this article we demonstrate that rAAV can integrate into human T cell lines and can maintain gene expression from an activation-dependent promoter.
Results

Vector construct
We constructed an AAV-based vector expressing the firefly luciferase gene (luc) under the regulatory control of the IL-2p as illustrated in Figure 1 . The neomycin resistance gene (neo R ) which is expressed by the SV40 promoter was inserted upstream of the IL-2p. The construct pAAV/IL-2p/luc/neo R (pAAV-luc) is flanked by the AAV ITR and excludes the rest of the AAV genome. Adeno-virus-free rAAV/IL-2p/luc/neo R (rAAV-luc) was generated from pAAV.
Activation-dependent expression of luciferase in pAAVluc-transfected T cell lines
We examined the capacity of pAAV-luc to transfer IL2p-dependent expression in transient transfection assays using the human T cell line Jurkat. Jurkat T cells were transfected with increasing amounts of pAAV-luc (0-60 g) and stimulated with phorbol myristate acetate (PMA, 20 ng/ml) and increasing concentrations of ionomycin (0-2.5 m) for 6 h. Figure 2 shows that there was no detectable luciferase expression in the absence of activation. PMA and ionomycin-induced luciferase expression by transfected Jurkat T cells was dependent on the amount of plasmid DNA transfected and on the concentration of ionomycin. Luciferase expression Persistence of luciferase expression by pAAV-luctransfected Jurkat T cells In order to examine long-term expression from pAAVluc, stable transfection of Jurkat T cells with pAAV-luc was achieved by selection for cells resistant to the neomycin analogue G418. G418 was added to pAAV-luctransfected Jurkat T cells 48 h after transfection and the cells were maintained for at least 180 days. Figure 3 shows the mean luciferase expression by transfected Jurkat T cells from three independent experiments. Cells were withdrawn at the indicated intervals and examined for luciferase activity in the presence or absence of stimulation with PMA and ionomycin. There was no detectable luciferase expression in the absence of stimulation over the entire 180 day period. PMA and ionomycin-induced luciferase expression was maximal immediately after transfection, was not detectable at 5 and 10 days after transfection (3 and 8 days after the addition of G418), but was detectable at 15 days and throughout the rest of the 180 day period.
Luciferase expression by pAAV-luc-transfected Jurkat T cell clones G418-resistant Jurkat T cells were cloned by limiting dilution 50 days after transfection with pAAV-luc and seven clones were isolated. Each clone was maintained in the presence or absence of G418 and examined for activation-induced luciferase expression (Figure 4a) . Two of the Jurkat clones had undetectable or minimally detectable luciferase activity while five clones expressed luciferase after stimulation with PMA and ionomycin for 6 h. In the absence of G418, activation-dependent luciferase activity persisted in the five clones. One of the five clones expressed higher levels of luciferase in the absence of G418 than in its presence. However, in the other four clones, activation-dependent luciferase activity in the absence of G418 was moderately decreased in two clones and was severely decreased in the other two clones. Next, we isolated genomic DNA from each of the seven clones to look for persistence of the luciferase gene. PCR amplification of genomic DNA using primer pairs specific for the luciferase gene amplified a fragment of expected size (1 kb) from six of the seven clones ( Figure 4b ). PCR amplification demonstrated the presence of the luciferase gene in all five luciferase-expressing clones and in one of the non-expressing clones. The other non-expressing clone appeared to have lost the luciferase gene because a luciferase fragment was not detectable by PCR.
Luciferase expression in Jurkat T cells infected with rAAV-luc
We next examined the capacity of rAAV-luc to transfer IL-2p-dependent expression into human T cell lines. Jurkat T cells were infected with rAAV-luc at an increasing multiplicity of infection (MOI) ranging from 1 × 10 4 to 4 × 10 4 particles per cell for 24 h. In contrast to the pAAVluc-transfected Jurkat T cells, there was no detectable luciferase activity in rAAV-luc-infected Jurkat T cells after stimulation with PMA and ionomycin for up to 20 days at any MOI tested (data not shown). Expression from the rAAV genome has been shown to be dependent on the synthesis of a second DNA strand from the singlestranded rAAV genome which can be enhanced by subjecting the infected cells to a variety of stimuli such as heat shock, UV irradiation, hydroxyurea and infection with adenovirus. 26, 27 Therefore, we subjected rAAV-lucinfected Jurkat T cells to heat shock at 42.5°C for 0.5-3 h or to UV irradiation (1-25 J/m 2 ). Treatment with heat shock or UV irradiation slightly enhanced PMA and ionomycin-induced luciferase activity to a maximum of 15 relative light units (data not shown). Therefore, transduced Jurkat T cells were selected in G418 2 days after infection with 4 × 10 4 particles per cell for 24 h without any additional treatment. Activation-dependent luciferase gene expression was detectable at 20 days and persisted for at least 180 days ( Figure 5 ). Luciferase gene expression was not detectable in unstimulated rAAV-lucinfected Jurkat T cells for at least 180 days.
Control of luciferase expression by the IL-2p
We examined the responsiveness of luciferase expression in rAAV-luc-infected Jurkat T cells to activators and inhibitors of IL-2 expression. Recombinant AAV-infected Jurkat T cells were stimulated with anti-CD3 antibody or with PMA and ionomycin in the absence or presence of cyclosporin A (CsA), an inhibitor of IL-2 expression. Anti-CD3 antibody stimulated a four-to five-fold increase in luciferase expression as compared to unstimulated cells (Figure 6a ). Anti-CD3 induced luciferase expression was totally inhibited by pre-incubation with CsA. PMA and ionomycin induced a greater degree of luciferase expression than anti-CD3 antibody but were also totally inhibited by pre-incubation with CsA ( Figure  6b ) indicating that expression of luciferase remained under the regulatory control of the IL-2p.
Luciferase expression in rAAV-luc-infected T cell clones Jurkat T cells were cloned by limiting dilution 40 days after infection with rAAV-luc and seven independent G418-resistant clones were obtained. Activation-induced luciferase expression was examined in all seven clones (Figure 7a ). Only two of seven Jurkat T cell clones expressed luciferase after stimulation with PMA and ion- omycin while the five other clones showed no detectable luciferase expression despite their ability to grow in G418. Genomic DNA was isolated from all of the rAAVluc-infected Jurkat T cell clones and a 1 kb luciferase gene fragment was amplified by PCR in only three of the clones (Figure 7b) . Two of these clones expressed luciferase upon activation whereas the third clone did not. All four clones with no PCR-amplifiable luciferase gene did not express luciferase upon activation.
Integration of rAAV-luc in Jurkat T cells Detection of the luciferase gene by PCR in genomic DNA from rAAV-luc-infected Jurkat T cell clones does not indicate whether the rAAV-luc construct has integrated into the chromosomal DNA. In order to determine whether rAAV-luc does integrate into the chromosomal DNA, genomic DNA was examined for the rAAV-luc construct by Southern blot analysis and FISH. HindIIIdigested genomic DNA from rAAV-luc-infected Jurkat T cell clones was subjected to pulse-field gel electrophoresis and Southern blot analysis. The blot was hybridized successively with a neo R probe and with a luciferase probe. The HindIII restriction enzyme cuts on both sides of the IL-2p in the rAAV-luc proviral genome resulting in three fragments of 0.6, 1.8 and 2.2 kb size containing the IL2p, neo R and luciferase genes, respectively. Southern blot analysis should result in a 1.8 kb neo R -positive band and a 2.2 kb luciferase-positive band if the rAAV-luc genome remained episomal. However, if the rAAV-luc genome integrated into chromosomal DNA, the size of the resulting bands would depend on the closest HindIII site to the site of integration. Figure 8 shows that six of the seven clones had integrated the rAAV-luc genome because the neo R -probed blot showed bands larger than 1.8 kb. However, only three of the seven clones had a positive signal with the luciferase probe. One of these clones was clone 2 which also had two bands that can be explained by a head-to-tail or tail-to-head concatamer of the rAAV-luc because the large band is the same size hybridized with both Neo R and Luc probes or by the presence of more than one clone.
FISH analysis of the rAAV-luc infected Jurkat T cell line and clone 2 showed evidence of integration of the rAAV genome into the host chromosomes ( Figure 9 ). In the rAAV-luc-infected cell line, 22.5% (45/200) of metaphase spreads analyzed showed evidence of rAAV integration. Of the positive metaphase spreads, 77.7% (35/45) had one signal on one chromosome, 13% (6/45) had two signals on two different chromosomes with none of the signals on the same chromosome, 6.6% (3/45) had three signals on three different chromosomes and 2.2% (1/45) had six signals on six different chromosomes (data not shown). In clone 2, 29% (58/200) of the metaphase spreads analyzed showed evidence of rAAV integration. Of the positive metaphase spreads, 53.4% (31/58) had one signal on one chromosome, 29.3% (17/58) had two signals on two different chromosomes, 5.1% (3/58) had two signals on the both sister chromosomes, 10.3% (6/58) had three signals on three different chromosomes, and 1.7% (1/58) had six signals on six different chromosomes. Figure 9 shows results of FISH analysis from two representative cells from clone 2. Although FISH analysis is not strictly quantitative, the results of the FISH data corroborate the results of the Southern blot analysis and show that rAAV/luc vectors are capable of integrating into the chromosomes of transduced Jurkat T cells.
Discussion
In this report, we demonstrate that rAAV can transfer and integrate regulated gene expression into the chromosomes of lymphocytic cells. Therefore, rAAV may be a useful vector for the transfer of regulated expression of CD40 ligand into T cells. We used the IL-2p to drive expression of the firefly luciferase gene in T cell lines as an example of an activation-dependent promoter. Activation of T cells via the T cell receptor (antigen receptor) / CD3 complex results in a signaling cascade leading to the activation of protein kinase C (PKC) and to a sustained rise in the intracellular concentration of calcium. [28] [29] [30] Activation of PKC leads to the activation of the fos and jun family of proteins that form the transcription factor activation protein 1 (AP-1). Increase of the intracellular concentration of calcium causes the activation of calcium/calmodulin-dependent enzymes including the protein phosphatase calcineurin which dephosphorylates the cytoplasmic subunit of the transcription factor, nuclear factor of activated T cells (NF-AT). 25 NF-AT then translocates to the nucleus, where together with AP-1, it forms a functionally active NF-AT complex that regulates the transcription of the IL-2 gene. The phosphatase activity of calcineurin is inhibited by complexes of immunosuppressant drugs and their endogenous immunophilins, such as CsA and cyclophilin. [31] [32] [33] Transfection of Jurkat T cells with pAAV-luc resulted in activation-dependent expression of luciferase. Activation by PMA and ionomycin, which activate protein kinase C and increase the intracellular concentrations of
Figure 7 Luciferase expression by rAAV-luc-infected Jurkat T cell clones. (a) Seven clones were isolated from rAAV-luc-transfected Jurkat cells and grown in complete medium with G418. Aliquots were stimulated with PMA and ionomycin for 6 h and luciferase activity was measured. Five of the Jurkat clones had undetectable or minimally detectable luciferase activity while only two clones expressed luciferase after stimulation with PMA and ionomycin for 6 h. (b) PCR amplification of an approximately 1 kb luciferase band was performed on genomic DNA isolated from each of the rAAVluc-infected clones. Three of the seven clones showed evidence of the presence of the luciferase gene including one of the nonexpressing clones.
Figure 9 FISH analysis of rAAV-luc-infected Jurkat T cells. Metaphase spreads of clone 2 cells isolated from rAAV-luc-infected Jurkat T cells were stained with propidium iodide (a and d) and hybridized with FITC-labeled neo R and luc probes (b and e) as described in Materials and methods. Superimposed images show the chromosomes in red and the hybridized FITC signals in yellow (c and f). Recombinant AAV-luc-specific signals on both sister chromosomes (c) indicates successful replication of the integrated rAAV-luc genome during cellular DNA synthesis.
calcium, respectively, mimics the activation of T cells via the T cell receptor-CD3 complex. Transient and stable transfection of Jurkat T cells with pAAV-luc showed that PMA and ionomycin-responsive luciferase expression persisted for at least 180 days. Infection of Jurkat T cells by rAAV-luc also resulted in PMA and ionomycindependent expression of luciferase especially when the cells were selected for neomycin resistance cells. Expression from the rAAV genome is dependent on the synthesis of a second DNA strand from the singlestranded rAAV genome 26, 27 which explains the delay in expression of luciferase after infection in contrast to the double-stranded plasmid pAAV-luc. The addition of G418 allows the selective expansion of infected cells that have undergone second-strand synthesis and are capable of expressing the neo R gene. We attempted to enhance second-strand synthesis by subjecting the infected Jurkat T cells to heat shock or to UV irradiation which resulted in a slight enhancement of PMA and ionomycin-induced luciferase expression (data not shown). However, the relative activity obtained remained small compared with the activity obtained in G418-selected cells.
Expression of luciferase in rAAV-luc-infected Jurkat T cells remained under the control of the IL-2p. There was no constitutive expression of luciferase in unstimulated cells. Stimulation of transduced Jurkat T cells with anti-CD3 antibodies or more potently with PMA and ionomycin resulted in activation of luciferase expression. Both anti-CD3 and PMA and ionomycin-induced expression of luciferase were inhibited by CsA demonstrating further that there was no apparent effect of the rAAV ITR on the transcriptional activity of the IL-2p.
Recombinant AAV was able to integrate into the chromosomes of Jurkat T cells as demonstrated by the Southern blot data and by FISH analysis. Southern blot analysis of HindIII-digested genomic DNA from rAAV-infected Jurkat T cells showed neo R -positive bands that were larger in size than expected had the rAAV remained episomal. Clone 2 had two neo R -positive bands that could be explained by a head-to-tail or tail-to-head concatamer. FISH analysis of clone 2 cells and of uncloned cells demonstrated the presence of rAAV in the chromosomal DNA. Despite integration of rAAV into the host chromosomes, not all infected clones maintained inducible expression of luciferase. The Southern blot data showed that only three of the clones had a luciferase-positive band. PCR amplification of a luciferase fragment from genomic DNA confirmed the absence of the luciferase gene in four of the clones. These results indicate that some of the DNA in rAAV may be lost during selection in vitro. The neo R gene was not lost in the G418-resistant clones because without the neo R gene, cells would not survive selection by G418. The loss of transferred DNA may be a significant problem in rAAV-mediated gene transfer but it may not occur in vivo. Whether loss of some of the transferred DNA occurs in vivo needs to be examined further. The loss of expression from the transferred construct is another concern. One of the pAAVtransfected clones and one of the rAAV-infected clones had no significant luciferase expression despite the pres-ence of the luciferase gene as determined by PCR. The loss of expression from a recombinant construct is not likely to be specific to rAAV but rather to the nature of the construct itself. Nevertheless, this may be a significant obstacle to gene transfer.
We have demonstrated that rAAV can transfer and integrate regulated gene expression in T cell lines. The ITR do not affect gene expression in T cell lines indicating that rAAV may be a useful gene transfer vector for regulated gene expression. However, several obstacles remain such as the loss of some of the transferred DNA and loss of expression from the transferred DNA. In addition, our experiments do not examine the efficiency of rAAVmediated gene transfer. Efficiency of transduction by rAAV-luc is likely to be low at the MOI that was used. The absence of PMA and ionomycin-induced luciferase expression in unselected cells with only a slight enhancement with heat shock or UV irradiation suggests that the efficiency of transduction was low. Further experiments examining the efficiency of transduction of T cells and T cell lines as well as experiments using in vivo models are needed to help answer some of these questions and will be the subject of further investigation in our laboratory.
Materials and methods
Construction of pAAV/IL-2p/luc/neo R and generation of rAAV The recombinant AAV-based plasmid pZZ was kindly provided by Matthew During (Yale University). pZZ was derived from the AAV-based plasmid SSV9 34 by replacing the AAV genome except for the ITR with the multiple cloning site (MCS). The IL-2p (kindly provided by Gerald Crabtree, Stanford University, Palo Alto, CA, USA) was subcloned into the luciferase reporter plasmid pGL3 basic (Promega, Madison, WI, USA) at the HindIII site upstream of luciferase gene. A blunt-end SspI-DraI fragment from pBK/CMV (Stratagene, La Jolla, CA, USA) containing the neo R gene driven by the SV40 promoter was subcloned into pGL3/IL-2p at the SmaI site upstream of IL-2p. Using convenient restriction enzyme sites, the orientation of the neo R gene was determined to be in the opposite direction from the IL-2p/luc gene. The neo R gene/IL-2p/luciferase/SV40 poly A construct was isolated from pGL3 by digestion with Asp718 and BamHI and subcloned into the respective sites in pZZ generating pAAV/IL-2p/luc/neo R (pAAV-luc, Figure 1 ). Adenovirus-free rAAV (rAAV-luc) with a titer of 8 × 10 12 particles/ml was generated from pAAV-luc at the University of North Carolina Gene Therapy Vector Core (Chapel Hill, NC, USA) by Dr R Jude Samulski and Dr Douglas McCarty.
Cell lines and culture conditions
The Jurkat T cell line, a human acute lymphocytic leukemia cell line, was obtained from the American Type Tissue Culture (ATTC, Rockville, MD, USA) and was maintained in complete medium, RPMI 1640 containing 10% fetal bovine serum, 2 mmol/l glutamine, 100 U/ml penicillin and 0.1 mg/ml streptomycin.
Transfection conditions, cell cloning and luciferase assay Jurkat T cells were suspended at 5 × 10 6 cells/250 l complete medium and transfected with 30 g of pAAV-luc or as otherwise indicated, by electroporation at 250 V and 950 F. After electroporation, cells were cultured in complete medium at 37°C for 1-2 h and then resuspended in fresh medium. Stable transfection of Jurkat T cells was achieved by addition of 1 mg/ml G418 (GIBCO BRL, Gaithersburg, MD, USA) 48 h after transfection to select for neomycin-resistant cells. Transfected cells were cloned by limiting dilution in 96-well plates. All wells were examined after 2 h and wells with one cell per well were labeled and grown under G418 selection. Aliquots of cells were removed at the indicated time-points and left untreated or stimulated with 20 ng/ml PMA (Calbiochem, La Jolla, CA, USA) and 1.5 m ionomycin (Calbiochem), as otherwise indicated. In some experiments, cells were stimulated with anti-CD3 antibody (ATTC) coated on round-bottom 96-well plates at a concentration of 10 g/ml in phosphate-buffered saline at 4°C for 16 h. Cells (3 × 10 5 ) were lysed with detergent buffer (Promega), and luciferase activity was measured in 25 l of lysate after the addition of 50 l luciferin substrate (Promega) in a 96-well plate luminometer (Labsystems Luminoskan, Needham Heights, MA, USA).
Infection of Jurkat T cells with rAAV-luc
Jurkat T cells were suspended at a density of 1 × 10 6 /ml and infected with rAAV-luc at 4 × 10 4 particles per cell for 24 h at 37°C. The infected cells were then resuspended in fresh complete medium for 2 days after which 1 mg/ml G418 was added to select for neomycin-resistant cells. In some experiments, infected cells were subjected to heat shock at 42.5°C for 0.5-3h or to 1-25 J/m 2 of UV irradiation using a Stratalinker UV Crosslinker 2400 (Stratagene). Cloning was performed by limiting dilution and luciferase activity assayed on unstimulated and stimulated aliquots as described above.
Isolation of genomic DNA and PCR amplification Genomic DNA was isolated from transfected and infected Jurkat T cell clones as described. 35 PCR amplification of a 1 kb luciferase gene fragment was performed on 1 g DNA using a commercially available kit (PCR Master; Boehringer Mannheim, Indianapolis, IN, USA) using the forward primer, 5Ј-AAGATGGAACCG CTGGAGAGCAAC-3Ј; and reverse primer, 5Ј-TACC TGGCAGATGGAACCTCTTGG-3Ј. PCR amplification was performed for 30 cycles under the following conditions: 94°C for 1 min, 60°C for 2 min and 72°C for 3 min. PCR products were subjected to agarose gel electrophoresis and visualized by ethidium bromide staining.
Southern blot analysis
Genomic DNA was digested with HindIII for 16 h and subjected to pulse-field gel electrophoresis with a DNA separation field of 1-100 kb. Southern blotting was performed on to a nylon membrane (Boehringer Mannheim) as described. 35 The blot was hybridized with an ␣-32 PdCTP random prime-labeled 1.68 kb HindIII-Asp718 fragment of the neo R gene. After a 16 h exposure to radiographic film, the blot was stripped by boiling in 0.4 m NaOH and rehybridized with an ␣-32 P-dCTP random prime-labeled 2.0 kb HindIII-BamHI fragment from the luciferase gene and exposed to radiographic film for 16 h.
Fluorescence in situ hybridization (FISH) analysis FISH analysis was performed on a metaphase spread of infected Jurkat T cell chromosomes as described.
Twenty-one hours before harvest, colcemid (Sigma, St Louis, MO, USA) was added to infected Jurkat T cells at a final concentration of 0.05 g/ml to block cells in metaphase. After colcemid treatment, cells were harvest and fixed by hypotonic/methanol:acetic acid and slides were prepared. Two DNA fragments, luc-ITR and neo R -ITR, were isolated from pAAV-luc by digestion with HindIII and PvuII and labeled with biotin by nick-translation (Boehringer Mannheim). The slides were hybridized at 37°C overnight. Amplification and detection of the signal was achieved by incubation with FITC-conjugated avidin (PharMingen, San Diego, CA, USA), followed by incubation with a biotin-labeled chain (PharMingen), and finally by addition of a FITC-conjugated anti-chain antibody (Sigma). Chromosomal DNA was stained with propidium iodide (Sigma). The slides were visualized under an Olympus Fluorescence Microscope (Olympus America, Lake Success, NY, USA), IX-70 equipped with a 100X/1.30 oil lris U plan F1 objective and imaging of the pictures using the proven solution for image analysis system image-pro plus.
